共 110 条
[1]
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]
Ferlay J(2008)Prognostic factors in 1,038 women with metastatic breast cancer Ann Oncol 19 2012-2019
[3]
Soerjomataram I(1995)Oligometastases J Clin Oncol 13 8-10
[4]
Siegel RL(2019)Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial Lancet 393 2051-2058
[5]
Torre LA(2009)CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer Cardiovasc Intervent Radiol 32 38-46
[6]
Jemal A(2012)Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study Int J Radiat Oncol Biol Phys 83 878-886
[7]
Largillier R(2009)Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation—intermediate and long-term survival rates Radiology 253 861-869
[8]
Ferrero JM(2016)Percutaneous thermal ablation of breast cancer metastases in oligometastatic patients Cardiovasc Intervent Radiol 39 885-893
[9]
Doyen J(2017)Normal tissue constraints for abdominal and thoracic stereotactic body radiotherapy Semin Radiat Oncol 27 197-208
[10]
Barriere J(2017)Institutional experience in the treatment of colorectal liver metastases with stereotactic body radiation therapy Rep Pract Oncol Radiother 22 126-131